Core Insights - AMN Healthcare Services, Inc. reported adjusted earnings per share (EPS) of 30 cents for Q2 2025, a decline of 69.4% year over year, but exceeded the Zacks Consensus Estimate by 76.5% [1] - The company’s revenues for Q2 2025 were $658.2 million, down 11.1% year over year, yet also surpassed the Zacks Consensus Estimate by 0.9% [2] - AMN Healthcare's gross profit fell 14.5% year over year to $196.4 million, with a gross margin of 29.8% [7] Revenue Breakdown - The Nurse and Allied Solutions segment generated revenues of $381.9 million, down 13.7% year over year, with travel nurse staffing revenues declining by 25% [4] - The Physician and Leadership Solutions segment reported revenues of $174.5 million, a decrease of 6.2% year over year, with interim leadership revenues down 25% [5] - The Technology and Workforce Solutions segment's revenues totaled $101.8 million, down 9.3% year over year, with vendor management systems revenue declining by 31% [6] Margin and Financial Position - Selling, general & administrative expenses increased by 3.7% year over year to $154.6 million, while adjusted operating profit fell by 48.2% to $41.8 million [7] - AMN Healthcare ended Q2 2025 with cash and cash equivalents of $41.5 million, down from $55.8 million at the end of Q1 2025, and total debt decreased to $920 million from $1 billion [8] Future Guidance - For Q3 2025, AMN Healthcare expects revenues in the range of $610 million to $625 million, reflecting a decline of 9-11% compared to the prior year [11] - The company anticipates a decline of 11-14% in revenues for the Nurse and Allied Solutions segment and 12-14% for the Technology and Workforce Solutions segment in Q3 [12] Overall Assessment - The overall performance of AMN Healthcare in Q2 2025 was disappointing, with declines across all segments and contracting margins [13] - Despite the challenges, there was an encouraging uptick in Language interpretation services revenues and positive customer adoption of AMN Passport [14] - The recent sale of the Smart Square nurse scheduling software and the partnership with symplr is seen as a promising development for the company [15]

Core Viewpoint - AMN Healthcare Services, Inc. reported a significant decline in adjusted earnings per share and revenues for the first quarter of 2025, although the adjusted EPS exceeded consensus estimates. The company anticipates continued revenue declines across all segments in the upcoming quarter, raising concerns about its financial performance [1][10][12]. Revenue Summary - AMN Healthcare's total revenues for Q1 2025 were $689.5 million, reflecting a 16% decrease year over year, but surpassing the Zacks Consensus Estimate by 2.7% [2]. - The Nurse and Allied Solutions segment generated revenues of $413.3 million, down 20.4% year over year, with travel nurse staffing revenues declining by 36% [4]. - The Physician and Leadership Solutions segment reported revenues of $174.1 million, a decrease of 7.8% year over year, with locum tenens revenues down 3% [5]. - The Technology and Workforce Solutions segment's revenues totaled $102.2 million, down 9.4% year over year, although language interpretation services saw a 5% increase [6]. Margin Analysis - AMN Healthcare's gross profit fell by 23.1% year over year to $198.1 million, with a gross margin contraction of 264 basis points to 28.7% [7]. - Adjusted operating profit was $50.4 million, reflecting a 39% decline from the prior year, and the adjusted operating margin contracted 276 basis points to 7.3% [7]. Financial Position - At the end of Q1 2025, AMN Healthcare had cash and cash equivalents of $55.8 million, up from $10.6 million at the end of 2024. Total debt decreased to $1 billion from $1.060 billion [8]. - Net cash provided by operating activities was $92.7 million, compared to $81.4 million a year ago [8]. Guidance - For Q2 2025, AMN Healthcare expects revenues to be in the range of $645 million to $660 million, indicating an 11-13% decline compared to the previous year [10]. - The company anticipates a revenue decline of 14-17% in the Nurse and Allied Solutions segment, 8-10% in the Technology and Workforce Solutions segment, and 5-7% in the Physician and Leadership Solutions segment [11]. Market Reaction - Following the earnings report, AMN Healthcare's shares gained nearly 9.2% in after-hours trading, indicating a positive market reaction despite the overall disappointing financial performance [2].